Table 3.
Univariate and multivariate analysis with hazard ratio (HR) and confidence interval (CI) for the development of new digital ulcers in SSc patients with increased resistin level
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (CI) | p | HR (CI) | p | |
Resistin | 1.094 (1.035–1.157) | 0.001 | 1.078 (1.014–1.145) | 0.016 |
Nailfold capillaroscopic pattern (early) | 0.205 (0.063–0.674) | 0.009 | 0.381 (0.108–1.345) | 0.134 |
SSc subset | 1.915 (0.914–4.010) | 0.085 | – | – |
SSc-specific autoantibodies | 0.495 (0.224–1.096) | 0.222 | – | – |
Disease duration | 0.996 (0.936–1.061) | 0.905 | – | – |
mRSS | 1.077 (1.022–1.134) | 0.006 | 1.011 (0.933–1.095) | 0.789 |
DAI | 1.215 (1.079–1.369) | 0.001 | 1.070 (0.807–1.420) | 0.637 |
DSS | 1.152 (1.058–1.253) | 0.001 | 1.074 (0.872–1.323) | 0.502 |
The median value of resistin (ng/ml) is higher (p=0019) in SSc patients with new digital ulcers than in SSc patients without new digital ulcers
SSc systemic sclerosis, mRSS modified Rodnan skin score, DAI disease activity index, DSS disease severity scale